Arkolith/Insider Trading/BCRX/Form 4

Barnes Alane P

Chief Legal OfficerBIOCRYST PHARMACEUTICALS INC (BCRX) · full profile →Form 4 · filed Mar 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)150K$9.15$1.4M401K
Mar 16, 2026Option exercise(M)150K$5.51$827K551K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 16, 2026Option exercise(M)150K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000882796-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML